Effect of Intranasal Oxytocin on Resting-state Effective Connectivity in Schizophrenia. (27th June 2022)
- Record Type:
- Journal Article
- Title:
- Effect of Intranasal Oxytocin on Resting-state Effective Connectivity in Schizophrenia. (27th June 2022)
- Main Title:
- Effect of Intranasal Oxytocin on Resting-state Effective Connectivity in Schizophrenia
- Authors:
- Korann, Vittal
Jacob, Arpitha
Lu, Bonian
Devi, Priyanka
Thonse, Umesh
Nagendra, Bhargavi
Maria Chacko, Dona
Dey, Avyarthana
Padmanabha, Anantha
Shivakumar, Venkataram
Dawn Bharath, Rose
Kumar, Vijay
Varambally, Shivarama
Venkatasubramanian, Ganesan
Deshpande, Gopikrishna
Rao, Naren P - Abstract:
- Abstract: Objectives: Evidence from several lines of research suggests the critical role of neuropeptide oxytocin in social cognition and social behavior. Though a few studies have examined the effect of oxytocin on clinical symptoms of schizophrenia, the underlying neurobiological changes are underexamined. Hence, in this study, we examined the effect of oxytocin on the brain's effective connectivity in schizophrenia. Methods: 31 male patients with schizophrenia (SCZ) and 21 healthy male volunteers (HV) underwent resting functional magnetic resonance imaging scans with intra-nasal oxytocin (24 IU) and placebo administered in counterbalanced order. We conducted a whole-brain effective connectivity analysis using a multivariate vector autoregressive granger causality model. We performed a conjunction analysis to control for spurious changes and canonical correlation analysis between changes in connectivity and clinical and demographic variables. Results: Three connections, sourced from the left caudate survived the FDR correction threshold with the conjunction analysis; connections to the left supplementary motor area, left precentral gyrus, and left frontal inferior triangular gyrus. At baseline, SCZ patients had significantly weaker connectivity from caudate to these three regions. Oxytocin, but not placebo, significantly increased the strength of connectivity in these connections. Better cognitive insight and lower negative symptoms were associated with a greater increaseAbstract: Objectives: Evidence from several lines of research suggests the critical role of neuropeptide oxytocin in social cognition and social behavior. Though a few studies have examined the effect of oxytocin on clinical symptoms of schizophrenia, the underlying neurobiological changes are underexamined. Hence, in this study, we examined the effect of oxytocin on the brain's effective connectivity in schizophrenia. Methods: 31 male patients with schizophrenia (SCZ) and 21 healthy male volunteers (HV) underwent resting functional magnetic resonance imaging scans with intra-nasal oxytocin (24 IU) and placebo administered in counterbalanced order. We conducted a whole-brain effective connectivity analysis using a multivariate vector autoregressive granger causality model. We performed a conjunction analysis to control for spurious changes and canonical correlation analysis between changes in connectivity and clinical and demographic variables. Results: Three connections, sourced from the left caudate survived the FDR correction threshold with the conjunction analysis; connections to the left supplementary motor area, left precentral gyrus, and left frontal inferior triangular gyrus. At baseline, SCZ patients had significantly weaker connectivity from caudate to these three regions. Oxytocin, but not placebo, significantly increased the strength of connectivity in these connections. Better cognitive insight and lower negative symptoms were associated with a greater increase in connectivity with oxytocin. Conclusions: These findings provide a preliminary mechanistic understanding of the effect of oxytocin on brain connectivity in schizophrenia. The study findings provide the rationale to examine the potential utility of oxytocin for social cognitive deficits in schizophrenia. … (more)
- Is Part Of:
- Schizophrenia bulletin. Volume 48:Number 5(2022)
- Journal:
- Schizophrenia bulletin
- Issue:
- Volume 48:Number 5(2022)
- Issue Display:
- Volume 48, Issue 5 (2022)
- Year:
- 2022
- Volume:
- 48
- Issue:
- 5
- Issue Sort Value:
- 2022-0048-0005-0000
- Page Start:
- 1115
- Page End:
- 1124
- Publication Date:
- 2022-06-27
- Subjects:
- neuropeptide -- psychosis -- negative symptoms -- social cognition -- fMRI
Schizophrenia -- Periodicals
Schizophrenia -- Research -- Periodicals
616.898005 - Journal URLs:
- http://schizophreniabulletin.oxfordjournals.org ↗
http://schizophreniabulletin.oxfordjournals.org/archive ↗
http://ukcatalogue.oup.com/ ↗ - DOI:
- 10.1093/schbul/sbac066 ↗
- Languages:
- English
- ISSNs:
- 0586-7614
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8089.400000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23173.xml